Claritas Pharmaceuticals (CLAZF) Price & Analysis

23 Followers

CLAZF Stock Chart & Stats

$0.01

$0.00(0.00%)

At close: Jan 02 4:00 PM EST

$0.01

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume4.20K

Average Volume (3M)N/A

Market Cap

$797.53K

Enterprise ValueN/A

Total Cash (Recent Filing)$0.00

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta-2.34

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding37,786,587

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.00

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

CLAZF FAQ

What was Claritas Pharmaceuticals’s price range in the past 12 months?

Claritas Pharmaceuticals lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Claritas Pharmaceuticals’s market cap?

Claritas Pharmaceuticals’s market cap is $797.53K.

When is Claritas Pharmaceuticals’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Claritas Pharmaceuticals’s earnings last quarter?

Currently, no data Available

Is Claritas Pharmaceuticals overvalued?

According to Wall Street analysts Claritas Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Claritas Pharmaceuticals pay dividends?

Claritas Pharmaceuticals does not currently pay dividends.

What is Claritas Pharmaceuticals’s EPS estimate?

Claritas Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Claritas Pharmaceuticals have?

Claritas Pharmaceuticals has 37,786,587 shares outstanding.

What happened to Claritas Pharmaceuticals’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Claritas Pharmaceuticals?

Currently, no hedge funds are holding shares in CLAZF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Claritas Pharmaceuticals

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.